Expression of nerve growth factor and matrix metallopeptidase-9/tissue inhibitor of metalloproteinase-1 in asthmatic patients

References

• Nockher WA, Renz H. Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J Allergy Clin Immunol 2006;117:5835–5889
   Google Scholar
• Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996;93:10955–10960
   PubMed Web of Science ®Google Scholar
• Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002;147:717–719
   Google Scholar
• Kassel O, de Blay F, Duvernelle C, Olgart C, Israel-Biet D, Krieger P, Moreau L, et al. Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low-dose. Clin Exp Allergy 2001;31:1432–1440
   PubMed Web of Science ®Google Scholar
• Olgart Höglund C, de Blay F, Oster JP, Duvernelle C, Kassel O, Pauli G, Frossard N. Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J 2002;20:1110–1116
   PubMed Web of Science ®Google Scholar
• Nassenstein C, Schulte-Herbrüggen O, Renz H, Braun A. Nerve growth factor: the central hub in the development of allergic asthma? Eur J Pharmacol 2006;533:195–206
   PubMed Web of Science ®Google Scholar
• Atkinson JJ, Senior RM. Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 2003;28:12–24
   PubMed Web of Science ®Google Scholar
• Cataldo DD, Bettiol J, Noël A, Bartsch P, Foidart JM, Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 2002;122:1553–1559
   PubMed Web of Science ®Google Scholar
• Bossé M, Chakir J, Rouabhia M, Boulet LP, Audette M, Laviolette M. Serum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma. Am J Respir Crit Care Med 1999;159:596–602
   PubMed Web of Science ®Google Scholar
• Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, Maquart FX, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001;98:6162–6167
   PubMed Web of Science ®Google Scholar
• Freund-Michel V, Bertrand C, Frossard N. TrkA signaling pathways in human airway smooth muscle cell proliferation. Cell Signal 2006;18:621–627
   Google Scholar
• Dagnell C, Kemi C, Klominek J, Eriksson P, Sköld CM, Eklund A, Grunewald J, et al. Effects of neurotrophins on human bronchial smooth muscle cell migration and matrix metalloproteinase-9 secretion. Transl Res 2007;150:303–310
   PubMedGoogle Scholar
• American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107–1136
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225–244
   PubMed Web of Science ®Google Scholar
• Nockher WA, Renz H. Neurotrophins and asthma: novel insight into neuroimmune interaction. J Allergy Clin Immunol 2006;117:67–71
   PubMed Web of Science ®Google Scholar
• Nadel JA. Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J 1991;4:745–754
   PubMed Web of Science ®Google Scholar
• Nassenstein C, Braun A, Erpenbeck VJ, Lommatzsch M, Schmidt S, Krug N, Luttmann W, et al. The neurotrophins nerve growth factor, brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma. J Exp Med 2003;198:455–467
   PubMed Web of Science ®Google Scholar
• Solomon A, Aloe L, Pe’er J, Frucht-Pery J, Bonini S, Levi-Schaffer F. Nerve growth factor is performed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 1998;102:454–460
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophil produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002;99:2214–2220
   PubMed Web of Science ®Google Scholar
• Raap U, Deneka N, Bruder M, Kapp A, Wedi B. Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects. Clin Exp Allergy 2008;38:1493–1498
   PubMed Web of Science ®Google Scholar
• O’Connor TM, O’Connor J, O’Brian DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167–180
   PubMed Web of Science ®Google Scholar
• Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989;337:362–364
   PubMed Web of Science ®Google Scholar
• Päth G, Braun A, Meents N, Kerzel S, Quarcoo D, Raap U, Hoyle GW, et al. Augmentation of allergic early-phase reaction by nerve growth factor. Am J Respir Crit Care Med 2002;166:818–826
   PubMed Web of Science ®Google Scholar
• Kerzel S, Päth G, Nockher WA, Quarcoo D, Raap U, Groneberg DA, Dinh QT, et al. Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. Am J Respir Cell Mol 2003;28:170–178
   Google Scholar
• Hoyle GW, Graham RM, Finkelstein JB, Nguyen KPT, Gozal D, Friedman M. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol 1998;18:149–157
   PubMed Web of Science ®Google Scholar
• Gueders MM, Foidart JM, Noel A, Cataldo DD. Matric metalloproteinases (MMPs) and tissue inhibitor of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006;533:133–144
   PubMed Web of Science ®Google Scholar
• Ogawa H, Azuma M, Uehara H, Takahashi T, Nishioka Y, Sone S, Izumi K. Nerve growth factor derived from bronchial epithelium after chronic mite antigen exposure contributes to airway hyperresponsiveness by inducing hyperinnervation, and is inhibited by in vivo siRNA. Clin Exp Allergy 2012;42:460–470
   Google Scholar
• Calikoğlu M, Unlü A, Tamer L, Ozgür E. MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma. Tuberk Toraks 2006;54:114–121
   PubMedGoogle Scholar
• Ko FW, Diba C, Roth M, McKay K, Johnson PR, Salome C, King GG. A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest 2005;127:1919–1927
   PubMed Web of Science ®Google Scholar
• Sands MF, Ohtake PJ, Mahajan SD, Takyar SS, Aalinkeel R, Fang YV, Blume JW, et al. Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. Clin Immunol 2009;130:186–198
   PubMed Web of Science ®Google Scholar
• Khan KM, Falcone DJ, Kraemer R. Nerve growth factor activation of Erk-1 and Erk-2 induces matrix metalloproteinase-9 expression in vascular smooth muscle cells. J Biol Chem 2002;277:2353–2359
   Google Scholar